Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Ann Surg. 2021 Apr 30;277(3):e617–e623. doi: 10.1097/SLA.0000000000004925

Table 3.

Multivariable Longitudinal Analyses Using Mixed Repeated Measures Models to Evaluate the Associations Between Mastectomy Status and Pain Outcomes

Variable Pain Severity Pain Interference
Estimated Coefficient Standard Error P Estimated Coefficient Standard Error P
Mastectomy Yes vs. No 0.36 0.23 .122 0.07 0.29 .804
Time Point x Mastectomy .069 .030
Pain Outcome Baseline 0.50 0.05 <.001 0.54 0.06 <.001
Assessment of Time Effect
 T2 (vs. T1) 0.04 0.13 .741 −0.04 0.15 .776
 T3 (vs. T1) −0.26 0.13 .038 −0.53 0.14 <.001
 T4 (vs. T1) −0.37 0.14 .007 −0.70 0.15 <.001
Age at diagnosis (years) 0.01 0.01 .204 −0.006 0.01 .531
Race/Ethnicity
 Black, non-Hispanic (vs. White, non-Hispanic) 0.97 0.33 .003 0.63 0.34 .067
 Hispanic (vs. White, non-Hispanic) 0.13 0.25 .605 0.03 0.30 .914
 Other/missing (vs. White, non-Hispanic) −0.21 0.29 .469 −0.18 0.35 .604
Chemotherapy Yes vs. No 0.48 0.19 .012 0.40 0.21 .058
Reconstruction Yes vs. No 0.20 0.26 .430 0.29 0.32 .363

NOTE. T1=1 month post-surgery; T2=6 months post-surgery; T3=12 months post-surgery; T4=18 months post-surgery.

Body mass index, adjuvant radiation therapy, and adjuvant hormone therapy were not significantly associated with pain severity or interference in the longitudinal univariate analysis and were not included in the multivariable analysis.